Results 141 to 150 of about 115,957 (308)

532‐nm KTP Laser Treatment of Epidermal Growth Factor Receptor Inhibitor–Associated Paronychia: A Case Report

open access: yesLasers in Surgery and Medicine, EarlyView.
ABSTRACT Objectives Paronychia is a common and often painful cutaneous adverse event of epidermal growth factor receptor inhibitor therapy that can impair function and quality of life. We report the first known case of amivantamab‐associated paronychia successfully treated with 532‐nm potassium‐titanyl‐phosphate laser.
Emilee M. Dreifus   +2 more
wiley   +1 more source

Report of Adverse Events Associated With Cutaneous Procedures: Update From the CAPER Registry

open access: yesLasers in Surgery and Medicine, EarlyView.
ABSTRACT Objectives To systematically evaluate submissions to the CAPER database by analyzing procedural context, characteristics of reported adverse events (AEs), and provider involvement in order to identify patterns with potential implications for patient safety.
Sabrina S. Smith   +9 more
wiley   +1 more source

Toxicity Differences Between Microplastics and Nanoplastics in Organs: From Molecular Mechanisms to Potential Therapeutic Strategies

open access: yesMed Research, EarlyView.
This review systematically compares the size‐dependent toxicity of microplastics and nanoplastics in the intestine, liver, kidney, lung, and brain. Particle size determines bioavailability, barrier penetration, and injury mechanisms. Because of their small size and high surface reactivity, NPs readily cross the intestinal epithelium and blood–brain ...
Yixian Cheng   +14 more
wiley   +1 more source

Advancing Therapies for Mycobacterial Diseases: From Small Molecules to Host‐Directed Strategies

open access: yesMedicinal Research Reviews, EarlyView.
ABSTRACT The global burden of multidrug‐resistant tuberculosis (MDR‐TB) and the rising incidence of nontuberculous mycobacterial (NTM) infections highlight the urgent need for innovative therapeutic strategies. Current treatments are prolonged, toxic, and increasingly compromised by resistance and limited diagnostic capacity.
Tânia Silva   +23 more
wiley   +1 more source

Pedunculated Extraocular Sebaceous Carcinoma With a Slender Stalk

open access: yes
JEADV Clinical Practice, EarlyView.
Mie Horiuchi   +6 more
wiley   +1 more source

A structured multidisciplinary home parenteral nutrition program in a public healthcare system: Implementation model, nursing‐led training protocol, and 11‐year safety outcomes

open access: yesNutrition in Clinical Practice, EarlyView.
Abstract Background Home parenteral nutrition (HPN) is the standard of care for adults with chronic intestinal failure (CIF), but evidence from publicly funded healthcare systems in middle‐income countries is limited. This study describes an 11‐year experience of a structured, nursing‐led HPN program within Brazil's Unified Health System (SUS ...
Tatiana da Cunha Rana   +5 more
wiley   +1 more source

Granuloma central de células gigantes. Caso clínico y tratamiento quirúrgico Central giant cell granuloma. Clinical case and surgical treatment

open access: yesRevista de la Asociación Odontológica Argentina, 2018
Resumen Objetivo: Describir y diagnosticar el granuloma central de células gigantes para poder seleccionar el tratamiento indicado, la enucleación, el curetaje o la resección en bloque de la lesión. Caso clínico: El paciente presentaba un granuloma
Néstor Rubén Consoli   +4 more
doaj  

Emerging Deep Cutaneous Fungal Infection Caused by Cyphellophora Species in a Diabetic Patient

open access: yes
The Kaohsiung Journal of Medical Sciences, EarlyView.
Yi‐Shan Teng   +2 more
wiley   +1 more source

Dedifferentiation in endometrial cancer is associated with HLA‐I silencing that may be restored by IFN‐γ

open access: yesThe Journal of Pathology, EarlyView.
Abstract Dedifferentiated endometrial carcinoma occurs when a prognostically favorable low‐grade endometrial carcinoma transforms into a highly aggressive undifferentiated carcinoma following genomic inactivation of core SWItch/Sucrose Non‐Fermentable (SWI/SNF) complex protein(s).
Antonio De Leo   +15 more
wiley   +1 more source

Aggressive Central Giant Cell Granuloma Case Report & Review of Literature

open access: yesJournal of Indian Academy of Oral Medicine and Radiology, 2005
First described by Jaffe in 1953, the Central Giant Cell Granuloma appears to be an enigmatic lesion unique to the jaws. The true nature of Central Giant Cell Granuloma remains unknown, despite considerable discussion and controversy in literature ...
C Krithika, S Jayachandran
doaj  

Home - About - Disclaimer - Privacy